An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis.

Citations & References

  • Authors: Rafei M, Berchiche YA, Birman E, Boivin MN, Young YK, Wu JH, Heveker N, Galipeau J,
  • Journal: J Immunol (2009) 183:1759-1766
  • ID: PN67535
d605ab0b3c70e445e642b4502ed01e4f_Citations